Treatment for Cardiovascular Diseases

Phase-Based Progress Estimates
Kaiser Permanente Center for Health Research, Portland, OR
Cardiovascular Diseases+2 More
All Sexes
Eligible conditions

Study Summary

This study is evaluating whether a computerized decision support system can improve cardiovascular disease care in community health centers.

See full description

Eligible Conditions

  • Cardiovascular Diseases
  • Stroke
  • Myocardial Infarction

Treatment Effectiveness

Effectiveness Estimate

1 of 3

Compared to trials

Study Objectives

This trial is evaluating whether Treatment will improve 1 primary outcome and 13 secondary outcomes in patients with Cardiovascular Diseases. Measurement will happen over the course of Up to 12 months.

Up to 12 months
Effectiveness (impact): Patient outcomes - not current smoker
Up to 36 months
Adoption: CDS uptake
Comparison of CVD outcomes for patients in CHCs
Effectiveness (impact): Patient outcomes - 10 year pooled ASCVD risk score
Effectiveness (impact): Patient outcomes - Framingham 30-year CVD risk score
Effectiveness (impact): Patient outcomes - appropriate aspirin use
Effectiveness (impact): Patient outcomes - appropriate cardioprotective medications
Effectiveness (impact): Patient outcomes - last A1c≤8
Effectiveness (impact): Patient outcomes - last BMI ≤25
Effectiveness (impact): Patient outcomes - last BP ≤140/90
Effectiveness (impact): Patient outcomes - last LDL<100
Implementation: User perceptions
Maintenance over time
Reach: Encounters affected

Trial Safety

Safety Estimate

1 of 3

Compared to trials

Trial Design

2 Treatment Groups

Arm 1: Immediate implementation
1 of 2
Arm 2: Delayed implementation
1 of 2
Active Control

This trial requires 60 total participants across 2 different treatment groups

This trial involves 2 different treatments. Treatment is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.

Arm 1: Immediate implementation
30 safety net community health centers (CHCs) will be randomized to implement the sophisticated CV Wizard clinical decision support (CDS) system at the start of study year 2. Arm 1 CHCs will receive implementation support that will be pragmatically iterated to address any barriers to adoption / sustained use of the CDS that are identified through study activities. The investigators will apply these learnings to improve adoption rates in Arm 2.
Arm 2: Delayed implementation
30 safety net community health centers (CHCs) will be randomized to implement the sophisticated CV Wizard clinical decision support (CDS) system 18 months later than Arm 1. The investigators will measure the intervention's impact on CVD risk factor control in CHCs.

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: up to 36 months
This trial has the following approximate timeline: 3 weeks for initial screening, variable treatment timelines, and roughly up to 36 months for reporting.

Closest Location

Kaiser Permanente Center for Health Research - Portland, OR

Eligibility Criteria

This trial is for patients born any sex aged 18 and older. There are 3 eligibility criteria to participate in this trial as listed below.

Mark “yes” if the following statements are true for you:
Adult clinic attendees with high CVD risk, including women and minorities
Persons aged 18-21 with high-CVD risk
Some subjects with mental health conditions of various types

Patient Q&A Section

Ask a question about the study

Other questions from users

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any geographic restrictions to consider when applying for this trial?

Patients from any state can participate in this trial, so long as they are able to attend all treatment sessions.

Will my insurance cover participating in this trial?

In order to understand how insurance coverage works for this trial, you will need to contact the study coordinator.

See if you qualify for this trial
Get access to this novel treatment for Cardiovascular Diseases by sharing your contact details with the study coordinator.